Pay in 4 interest-free payments of $7.11 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Compounding pharmacies involved in the preparation of synthetic peptides must adhere to stringent protocols to safeguard the integrity of these research materials
Early haematological response begins with reticulocytosis (increased production of immature red blood cells) typically by day 3-4 of treatment , particularly with injectable forms, though the full resolution of symptoms may take several weeks to months
In the original 2017 mouse study, FOXO4-DRI was reported as well-tolerated in vivo at the dosing used
Belghit I, Philip AJP, Maas RM, Lock E-J, Eding EH, Espe M, et al
Product Details Form: Capsules (for laboratory research) Amount per capsule: 500 mcg Quantity: 100 capsules Purity: 98% (HPLC tested) Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (15 amino acids) Molecular Formula: CHNO Molecular Weight: ~1419.5 g/mol Intended Use: Laboratory research only DISCLAIMER: This product is strictly to be used for scientific research use only
